AKESOgen and London Genetics International Alliance to Enhance Drug Development Through Pharmacogenetics and Related Services

News   Mar 30, 2012

 
AKESOgen and London Genetics International Alliance to Enhance Drug Development Through Pharmacogenetics and Related Services
 
 
 

RELATED ARTICLES

Progressive Kidney Disease: New Compound Restores Kidney Function

News

A team led by researchers describe a new approach to prevent death in these essential kidney cells. Studying multiple animal models of kidney disease, the team discovered a compound that can impede loss of the filtration cells and restore kidney function.

READ MORE

New Drug Delivery System Targets Diseases at a Genetic Level

News

A new drug delivery system that uses a synthetic-biological hybrid nanocapsule could provide a smart technology for targeted treatment of a variety of serious diseases at the genetic level.

READ MORE

Genes Unique to Mammals Identified

News

Scientists compared the genomes of 68 mammals, including Homo sapiens, and identified 6000 gene families unique to mammals. Comparisons were then made to proteomic and transcriptional data to look at which proteins were produced.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE